Been punished for slow sales but has been overdone. Sure LAD...

Been punished for slow sales but has been overdone. Sure LAD devices are not performing as hoped for resulting in poor balance sheet but the company has to be on a winner with eyecare alone. Patience will be rewarded with this one and if their clinical trials that are presently underway prove successful in the regrowth of the thymus to help produce tcells look out for the blue sky